Summary
Metipamide was monitored during a two month cap period of treatment to determine whether the wholeblood levels estimated by HPLC provide a relevant indicator of the possible accumulation of the drug., We also analysed antihypertensive activity and biochemical changes in blood of twenty hypertonic patients. Result showed that metipamide is an effective, first-line antihypertensive agent, combining statisfactory blood pressure reduction with low frequency of side effects and a simple once-daily dosage regime.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
R. J. Noveck, F. G. McMahon, A. Quiroz, T. Giles, Am Heart J.,106, 221–228 (1983).
J. H. Morledge, Am Heart. J.,106, 229–232 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Klíma, J., Grafnetterová, J., Kubelka, Z. et al. HPLC determination and antihypertensive effect of metipamide. Chromatographia 26, 206–208 (1988). https://doi.org/10.1007/BF02268152
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02268152